Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001992109-24-000001·Perspective Therapeutics, Inc.
Schedule 13G ownership disclosure
IsoRay, Inc.
Common Stock · CUSIP: 46489V104
Event date: 2023-12-31
- Filing-level shares
- 16,779,075.00
- Percent of class
- 5.9%
- Schultz Michael K
Shares: 16,779,075.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001992109-24-000001
- Form type
- SCHEDULE 13G/A
- Filer
- Perspective Therapeutics, Inc.
- CIK
- CIK 728387
- Filed
- Feb 05, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership